Cargando…

SAT401 The Aftermath Of Pueraria mirifica: A Case Of Hypertriglyceridemia And Necrotizing Pancreatitis In A Non-binary Individual With Surreptitious Use Of Oral Estrogenic Compounds

Disclosure: S. Tobolsky: None. F.J. Hayes: None. J. Lo: None. Background Prescription of gender-affirming hormone therapy (GAHT) has become an increasingly prevalent aspect of endocrine care meriting greater attention from our specialty. We report a case where surreptitious use of an unregulated com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tobolsky, Seth, Hayes, Frances J, Lo, Janet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Transgender Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554576/ http://dx.doi.org/10.1210/jendso/bvad114.2072

Ejemplares similares

SAT391 Supratherapeutic Estrogen Levels in Transgender Women Likely From Sublingual Estradiol
por: Jalal, Erica, et al.
Publicado: (2023)

SAT400 Evaluation Of Lipid Profile Of Transgender Women On Long-Term Estrogen Therapy
por: Mobilia Alvares, Leonardo Azevedo, et al.
Publicado: (2023)

Pueraria mirifica Exerts Estrogenic Effects in the Mammary Gland and Uterus and Promotes Mammary Carcinogenesis in Donryu Rats
por: Kakehashi, Anna, et al.
Publicado: (2016)

SAT420 Bone Health In Transgender People
por: Grande, Giuseppe, et al.
Publicado: (2023)

SAT396 Transgender Care From The VA Perspective
por: Nayak, Pratima R
Publicado: (2023)

SAT408 Assessment Of Family Planning Readiness In Transgender Youth
por: Conard, Ryan Steven, et al.
Publicado: (2023)

SAT407 Hematospermia In Transgender Woman Revealing Occult Endometriosis
por: Coleman-Belin, Janet C, et al.
Publicado: (2023)

Inhibition of LPS-Induced Microglial Activation by the Ethyl Acetate Extract of Pueraria mirifica
por: Jantaratnotai, Nattinee, et al.
Publicado: (2022)

SAT395 Gender Dysphoria In A Patient With Ovotesticular Disorder Of Sex Development
por: Moreno, Telma, et al.
Publicado: (2023)

SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023)

SAT397 A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment
por: Korpaisarn, Sira, et al.
Publicado: (2023)

Pueraria mirifica, an estrogenic tropical herb, unveiled the severity of Type 1 LQTS caused by KCNQ1‐T587M
por: Kashiwa, Asami, et al.
Publicado: (2021)

SAT392 A Case Of Idiopathic Intracranial Hypertension in Gender Dysphoria: Is Testosterone The Culprit?
por: Saad-Omer, Suhail, et al.
Publicado: (2023)

SAT406 Evaluation Of The Emotional And Cognitive Effects Of Hormone Therapy In Transgender Men And Women
por: Yaish, Iris, et al.
Publicado: (2023)

SAT412 Effects Of Gender-Affirming Hormone Therapy On The Connectivity Of Intrinsic Brain Networks
por: Pedreira, Clarissa C, et al.
Publicado: (2023)

SAT421 Near Term Cardiometabolic Outcomes of Testosterone Therapy In Transgender Boys And Men
por: Dey, Justin, et al.
Publicado: (2023)

SAT402 A Multimodal Curriculum To Improve Medical Student Gender-affirming Communication Skills
por: Jones, Robert Benson, et al.
Publicado: (2023)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

SAT417 Comparison Of Mental Health Status In Transgender And Gender Diverse Versus Cisgender People
por: Pedreira, Clarissa C, et al.
Publicado: (2023)

SAT645 Cardiac Autonomic Modulation In Transgender Men Under Gender-affirming Hormone Therapy
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2023)

SAT398 Pubertal Status And Trends In Gender Affirming Treatment Of Transgender And Gender Diverse Youth
por: Lin, Cathy, et al.
Publicado: (2023)

SAT410 Echocardiogram Analysis Of Transgender Women Amateur Athletes Undergoing Gender-affirming Hormone Therapy
por: Mobilia Alvares, Leonardo Azevedo, et al.
Publicado: (2023)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

SAT414 Gender Identity And Sexual Orientation Among Patients Evaluated By Psychiatric In A Pediatric ED
por: Alejandro, Diaz, et al.
Publicado: (2023)

SAT419 Characteristics Of Trans Male Children And Adolescents Care Followed Up In A Children Hospital
por: Esposito, Mariela, et al.
Publicado: (2023)

SAT405 Bone Analysis Of Transgender Women Amateur Athletes Undergoing Gender-affirming Hormone Therapy
por: dos Santos, Lívia Marcela, et al.
Publicado: (2023)

Transcriptome analysis of Pueraria candollei var. mirifica for gene discovery in the biosyntheses of isoflavones and miroestrol
por: Suntichaikamolkul, Nithiwat, et al.
Publicado: (2019)

Transformation of Pueraria candollei var. mirifica phytoestrogens using immobilized and free β-glucosidase, a technique for enhancing estrogenic activity
por: Makkliang, Fonthip, et al.
Publicado: (2021)

SAT418 Nurse-Led Care For Transgender And Gender Diverse Individuals: A Cross-Sectional Study Of International Context And Practice
por: Greenspan, Debra Lynn, et al.
Publicado: (2023)

SAT393 Resilience And Resistance In The Face Of Stigma And Trauma: A Qualitative Study Of Transgender People’s Reactions To Interactions With The Healthcare System
por: Stroumsa, Daphna, et al.
Publicado: (2023)

SAT403 Long-term Metabolic Effects Of Gonadotropin Releasing Hormone Agonist (GnRH) Therapy In Transgender Women Veterans
por: Le, Guillaume, et al.
Publicado: (2023)

OR31-01 The Dose-dependent Effect Of Estrogen On Bone Mineral Density In Trans Girls
por: Boogers, Lidewij S, et al.
Publicado: (2023)

SAT415 Development Of A Novel, Preclinical Swine Model Of Transgender Men To Assess Testosterone Impact On Insulin Sensitivity And Whole-Body Metabolism
por: Mahabir, Nirvana, et al.
Publicado: (2023)

SAT647 Quantifying The Effects Of Gender-Affirming Hormone Therapy On Bone Density Of Transgender Patients: Emerging Results Of A Single-center Study
por: Godar, Cassandra M, et al.
Publicado: (2023)

SAT404 Achieving Both Target Testosterone And Target Estradiol Levels May Not Be Practical In All Trans Feminine Users Of Estradiol - Which To Prioritize?
por: Slack, Daniel, et al.
Publicado: (2023)

SAT646 Cutaneous Manifestations In Adults With Gender Dysphoria Under Treatment Hormonal In External Consultation Of The Hospital De San José , Bogotá Colombia
por: Cortes, Henry Tovar
Publicado: (2023)

SAT399 Are Gender-affirming Hormone Therapy Duration And Body Mass Index Associated With Bone Mineral Density In Transgender And Gender Diverse Adults?
por: Iwamoto, Sean J, et al.
Publicado: (2023)

SAT394 Over-representation Of Adoptees Among Transgender Subjects Seeking Gender-Affirming-Hormonal-Therapy (GAHT) In A Large Tertiary Medical Center
por: Yaish, Iris, et al.
Publicado: (2023)

SAT644 Gender Affirming Hormone Therapy (GHAT) In Adult Male-to-female Mice Increases Cortical And Trabecular Bone, Resulting In An Increase In Bone Strength
por: Zajac, Jeffrey D, et al.
Publicado: (2023)

SAT409 Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study
por: Yaish, Iris, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_odc7uvdfbvciplrd9oi9ngqs5d